The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 19, 2018

Filed:

Nov. 09, 2015
Applicant:

Ohio University, Athens, OH (US);

Inventors:

Xiaozhuo Chen, Athens, OH (US);

Stephen Bergmeier, Athens, OH (US);

Assignee:

Ohio University, Athens, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 205/32 (2006.01); C07C 211/48 (2006.01); C07C 39/367 (2006.01); C07C 43/23 (2006.01); C07C 235/56 (2006.01); C07C 43/253 (2006.01); C07D 209/08 (2006.01); C07D 231/12 (2006.01); C07D 233/64 (2006.01); C07D 235/18 (2006.01); C07D 249/08 (2006.01); C07D 319/20 (2006.01); C07D 311/16 (2006.01); C07D 311/82 (2006.01); A61K 31/09 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07C 205/32 (2013.01); A61K 31/09 (2013.01); A61K 45/06 (2013.01); C07C 39/367 (2013.01); C07C 43/23 (2013.01); C07C 43/253 (2013.01); C07C 211/48 (2013.01); C07C 235/56 (2013.01); C07D 209/08 (2013.01); C07D 231/12 (2013.01); C07D 233/64 (2013.01); C07D 235/18 (2013.01); C07D 249/08 (2013.01); C07D 311/16 (2013.01); C07D 311/82 (2013.01); C07D 319/20 (2013.01);
Abstract

Glucose deprivation is an attractive strategy in cancer research and treatment. Cancer cells upregulate glucose uptake and metabolism for maintaining accelerated growth and proliferation rates. Specifically blocking these processes is likely to provide new insights to the role of glucose transport and metabolism in tumorigenesis, as well as in apoptosis. As solid tumors outgrow the surrounding vasculature, they encounter microenvironments with a limited supply of nutrients leading to a glucose deprived environment in some regions of the tumor. Cancer cells living in the glucose deprived environment undergo changes to prevent glucose deprivation-induced apoptosis. Knowing how cancer cells evade apoptosis induction is also likely to yield valuable information and knowledge of how to overcome the resistance to apoptosis induction in cancer cells. Disclosed herein are novel anticancer compounds that inhibit basal glucose transport, resulting in tumor suppression and new methods for the study of glucose deprivation in animal cancer research.


Find Patent Forward Citations

Loading…